|
|
![final program](../images/final_prog.gif)
Tuesday,
July 27, 2010
TUESDAY, JULY 27, 2010 |
08:30 - 10:45 |
|
HALL
A |
|
PL15
Plenary
Session
WHAT IS NEW IN CARDIOMYOPATHIES?
Chairpersons:
U. Elkayam, Los Angeles, CA, USA
M.A. Rossi, Ribeirao Preto, Brazil |
|
08:30 |
LEADS FROM MEDICINAL PLANTS TO TREAT DIABETIC CARDIOMYOPATHY (Invited Lecture)
R.K. Goyal, The Maharaja Sayajirao University of Baroda, Gujarat, India |
380 |
08:45 |
RELATIONSHIP BETWEEN LEFT VENRICULAR EJECTION FRACTION AND RECOVERY OF VENTRICULAR FUNCTION IN WOMEN WITH PERIPARTUM CARDIOMYOPATHY (Invited Lecture)
U. Elkayam, University of Southern California, Los Angeles, CA, USA |
382 |
09:00 |
PATHOGENESIS OF PARVO B19 (B19V) INDUCED INFLAMMATORY CARDIOMYOPATHY (DCMI)
H-P. Schultheiss, Charite – University Medicine Berlin,
Campus Benjamin Franklin, Medical Clinic II, Cardiology, Berlin, Germany |
383 |
09:15 |
A NOVEL STRATEGY TO ELUCIDATE COMPLEX PATHOGENESIS OF HCM SUBSET PROGRESSING TO THE DILATED PHASE, BASED ON THE AUTOPSY FINDINGS, GENOME-WIDE MASS-SCREENING AND BIOINFORMATICS (Invited Lecture)
T. Toyo-oka, M. Kobayashi, K. Takazawa, T. Tanaka,
S. Kostin, T. Izumi,
J. Schaper, Y. Nakamura, University of Tokyo, Japan |
384 |
09:30 |
A PREFERRED TIME FOR ONSET OF TAKO-TSUBO CARDIOMYOPATHY? (Invited Lecture)
R. Manfredini, Hospital of Delta, Lagosanto, and University of Ferrara, Italy |
385 |
09:45 |
MYOCARDIAL ISCHEMIA IN HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
J. Shirani, Geisinger Medical, Danville, PA, USA |
386 |
10:00 |
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA: MORE COMMON THAN PREVIOUS THOUGHT
(Invited Lecture)
S.N. Koulouris, Evangelismos Hospital, Athens, Greece |
387 |
10:15 |
REVERSE OR INVERTED TAKO-TSUBO CARDIOMYOPATHY (REVERSE LEFT VENTRICULAR APICAL BALLOONING SYNDROME) PRESENTS AT A YOUNGER AGE COMPARED TO MID OR APICAL VARIANT AND IS ALWAYS ASSOCIATED WITH TRIGGERING STRESS
R. Ramaraj, M.R. Movahed, University of Arizona, Tucson, AZ, USA |
388 |
10:30 |
ADIPONECTIN EXPRESSION IN PATIENTS WITH INFLAMMATORY CARDIOMYOPATHY INDICATES FAVOURABLE OUTCOME AND INFLAMMATION CONTROL
C. Skurk, P. Bobbert, A. Jenke, J. Stehr, S. Wilke,
U. Eriksson,
H.P. Schultheiss, C. Scheibenbogen, Charite, Berlin, Germany |
389 |
10:45 |
COFFEE BREAK, VISIT POSTERS & EXHIBITION |
|
TUESDAY, JULY 27, 2010 |
08:30 - 10:30 |
|
HALL
B |
|
PL16 Plenary Session
CARDIOVASCULAR EPIDEMIOLOGY / ROLE OF LIFESTYLE CHANGES / MODIFICATION OF DYSLIPOPROTEINEMIA
Chairpersons:
M.H. Criqui, La Jolla, CA, USA
A. Klatsky, Oakland, CA, USA
|
|
08:30 |
INCREASING LIFE EXPECTANCY IN THE WESTERN WORLD AND THE ROLE OF CARDIOVASCULAR PREVENTION (Invited Lecture)
U. Keil, University of Muenster, Germany |
390 |
08:45 |
AN UPDATE ON CARDIOVASCULAR DISEASE RISK PREDICTION FROM THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (Invited Lecture)
M.H. Criqui, University of California, San Diego, La Jolla, CA, USA |
391 |
09:00 |
WINE, BEER, AND CARDIOVASCULAR CONDITIONS: SCIENTIFIC TRUTHS IN A NEW DECADE (Invited Lecture)
A. Klatsky, Kaiser Permanente Medical Center, Oakland, CA, USA |
392 |
09:15 |
CARDIOVASCULAR DISEASE IN THE ASIANS - PHARMACOGENETIC DIFFERENCES (Invited Lecture)
G.L. Fung, UCSF Medical Center at Mt. Zion, San Francisco, CA, USA |
393 |
09:30 |
GENDER DIFFERENCES IN EXERCISE TESTING IN A CARDIOLOGY PRACTICE (Invited Lecture)
Y. Charuzi, UCLA School of Medicine, Los Angeles, CA, USA |
394 |
09:45 |
IS THERE EVIDENCE FOR THERAPEUTIC GOALS BEYOND LDL-C? (Invited Lecture)
J.G. Robinson, University of Iowa, Iowa City, IA, USA |
395 |
10:00 |
CARBAMYLATED LDL - MISSING LINK BETWEEN UREMIA AND ATHEROSCLEROSIS (Invited Lecture)
A.G. Basnakian, University of Arkansas for Medical Sciences, Little Rock,
AR, USA |
396 |
10:15 |
EFFICACY AND SAFETY OF LONG-TERM ROSUVASTATIN TREATMENT IN HIGH CARDIOVASCULAR RISK PATIENTS (Invited Lecture)
S.Chumburidze, National Center of Therapy, Tbilisi, Georgia |
397 |
10:30 |
COFFEE BREAK, VISIT POSTERS & EXHIBITION |
|
TUESDAY, JULY 27, 2010 |
08:30 - 11:00 |
|
HALL
C |
|
S35
Session
INTERVENTIONAL CARDIOLOGY
Chairpersons:
B.F. Uretsky, Little Rock, AR, USA
G.W. Vetrovec, Richmond, VA, USA
|
|
08:30 |
IN-SITU ENDOTHELIALISATION POTENTIAL OF A NOVEL NANOCOMPOSITE POLYMER COATING FOR CORONARY STENTS
R. Bakhshi, H. Ghanbari, M. Marashi, A. Darbyshire,
G. Hamilton,
A.M. Seifalian, Division of Surgery and Interventional Science, University College London, UK |
398 |
08:45 |
IN-HOSPITAL OUTCOMES OF CONTEMPORARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH CHRONIC TOTAL OCCLUSION
H. Tanaka, Y. Morino, T. Kimura, Y. Hayashi,
T. Muramatsu, M. Ochiai,
Y. Noguchi, K. Kato,
Y. Shibata, Y. Hiasa, O. Doi, T. Yamashita,
T. Morimoto, M. Abe, T. Hinohara, K. Mitsudo, For the J-CTO Registry Investigators, Kurashiki Central Hospital (HT, MK), Kurashiki, Japan |
399 |
09:00 |
36-MONTH CLINICAL OUTCOME OF PROSPECTIVE MULTI-CENTER REGISTRY OF EXCEL BIODEGRADABLE POLYMER DRUG ELUTING STENTS (CREATE)
Y-L. Han, Q-M. Jin, X-M. Shang, L-X. Yang, W-M. Li,
H-L. Liu, Z-Q. Li,
T-M. Jiang, L. Huang, Y-D. Chen,
Shenyang Northern Hospital, Shenyang, China |
400 |
09:15 |
DOES GENDER INFLUENCE RESTENOSIS AFTER CAROTID ARTERY STENTING?
D. Mannheim, T. Salamon, R. Karmeli, Carmel Medical Center, Haifa, Israel |
401 |
09:30 |
OUTCOMES OF ROBOT-ASSISTED VASCULAR SURGERY, 150 CASES
P. Stadler, L. Dvoracek, P. Vitasek, P. Matous,
Na Homolce Hospital, Prague, Czech Republic |
402 |
09:45 |
OUTCOME OF DRUG-ELUTING STENT IN HIV-INFECTED PATIENTS
N. Jallad, A. QaQa, J. Daoko, E. Alberaqdar,
A. Hamdan, A. Al-dehneh,
M. Bikkina, F. Shamoon,
St Michaels Medical Center/Seton Hall University, Newark, NJ, USA |
403 |
10:00 |
COMPARISON OF RADIATION DOSE IN FEMORAL AND RADIAL ARTERIAL ACCESS CORONARY PROCEDURES; THE EFFECT OF OPERATOR EXPERIENCE
J. Neill, H. Douglas, G. Richardson, E. Chew,
S. Walsh, C. Hanratty, N. Herity,
Belfast City Hospital Cardiology Centre, Belfast, Northern Ireland, UK |
404 |
10:15 |
RADIATION DOSE DURING CORONARY ANGIOGRAPHY: CORRELATION TO BMI
A. Shah, P.K. Das, E. Subkovas, M. Payne, A. Azzu, Rees M, C.M. Bellamy,
Glan Clwyd Hospital, Bodelwyddan, UK |
405 |
10:30 |
PRE-PCI ATORVASTATIN: A RANDOMIZED STUDY
J. Veselka, D. Zemanek, L. Martinkovicova, M. Maly,
P. Hajek, R. Adlova, D. Tesar
CardioVascular Center, University Hospital Motol, Prague, Czech Republic |
406 |
10:45 |
ALTERNATE DAY CLOPIDOGREL THERAPY IS EFFICACIOUS TO PREVENT LATE STENT THROMBOSIS WITH DRUG ELUTING STENTS
S. Sharma, K. Bhalla, B. Bhambi, W. Nyitray,
K. Desai, R. Sharma, A. Antonescu,
T. Ishimori, Central Cardiology/Bakersfield Heart Hospital, CA, USA |
407 |
11:00 |
COFFEE BREAK, VISIT POSTERS & EXHIBITION |
|
TUESDAY, JULY 27, 2010 |
11:00-13:00 |
|
HALL
A |
|
PL17
Plenary Session
NEW DIRECTIONS IN THE TREATMENT OF ISCHEMIC HEART DISEASE / INTERVENTIONAL CARDIOLOGY
Chairpersons:
J.H. Chesebro, Worcester, MA, USA
U. Thadani, Oklahoma City, OK, USA
|
|
11:00 |
TREATMENT OF STABLE ANGINA: UPDATE 2010
(Invited Lecture)
U. Thadani, University of Oklahoma, Oklahoma City, OK, USA |
408 |
11:15 |
CHEST PAIN EVALUATION IN THE EMERGENCY DEPARTMENT (Invited Lecture)
J.H. Chesebro, Umass Memorial Medical School and Medical Center,
Worcester, MA, USA |
409 |
11:30 |
PCI IN THE MANAGEMENT OF PATIENTS WITH IMPAIRED LEFT
VENTRICULAR FUNCTION
G.W. Vetrovec,
Virginia Commonwealth University, Richmond, VA, USA |
410 |
11:45 |
CURRENT STATUS OF ELECTIVE LEFT MAIN STENTING (Invited Lecture)
B.F. Uretsky, University of Arkansas for Medical Sciences, Little Rock,
AR, USA |
411 |
12:00 |
SERUM SRAGE, A PREDICTOR OF RESTENOSIS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION (Invited Lecture)
K. Prasad, University of Saskatchewan, Saskatoon, Canada |
412 |
12:15 |
DIO CEREBRAL RESUSCITATION FOR WITNESS CARDIAC ARREST VICTIMS (Invited Lecture)
M.R. Movahed, University of Arizona Sarver Heart Center, Tucson,
AR, USA |
414 |
12:30 |
ACUTE MYOCARDIAL INFARCTION IN CHILE BEFORE AND AFTER THE CHILEAN HEALTH REFORM
(Invited Lecture)
R.A. Diaz, University of Valparaiso, Chile |
415 |
12:45 |
THE SUCCESS OF REGIONALIZED STEMI RECEIVING CENTER NETWORKS (Invited Lecture)
I.C. Rokos, Geffen School of Medicine at UCLA, Los Angeles, CA, USA |
416 |
TUESDAY, JULY 27, 2010 |
11:00-13:30 |
|
HALL
B |
|
PL18 Plenary Session
VALVULAR HEART DISEASE
Chairpersons:
N.M. Rajamannan, Chicago, IL, USA
J. Ye, Vancouver, BC, Canada
|
|
11:00 |
EPIDEMIOLOGY OF CALCIFIC AORTIC VALVE DISEASE (Invited Lecture)
K.D. O'Brien, University of Washington, Seattle, WA, USA |
417 |
11:15 |
DESIGNING CLINICAL TRIALS IN VALVULAR HEART DISEASE: FROM BENCH O BEDSIDE (Invited Lecture)
N.M. Rajamannan, Northwestern University Feinberg School of Medicine, Chicago, IL, USA |
418 |
11:30 |
ADVANCES IN HEART VALVE SURGERY: TRANSCATHETER TRANSCARDIAC APPROACHES (Invited Lecture)
J. Ye, Columbia St. Paul's Hospital, Vancouver, BC, Canada |
419 |
11:45 |
VALVULAR HEART DISEASE; ECHOCARDIOGRAPHY VS CARDIAC MRI (Invited Lecture)
R.W.W. Biederman, Allegheny General Hospital, Pittsburgh, PA, USA |
420 |
12:00 |
EPIDEMIOLOGY OF VALVULAR HEART DISEASES. THE PROBLEM IS GROWING (Invited Lecture)
P. Supino, State University of New York (SUNY), NY, USA |
421 |
12:15 |
INCIDENCE OF EMBOLIC CEREBRAL INSULTS AFTER PERCUTANEOUS TRANSAPICAL AORTIC VALVE REPLACEMENT
D.S. Ropers, S. Ensminger, R. Feyrer, J. Ludwig,
A. Doerfler, M. Arnold
University of Erlangen, Germany |
422 |
12:30 |
4D FLOW MRI EVALUATION OF BICUSPID AORTIC VALVE PATIENTS: ASYMMETRICALLY ELEVATED WALL SHEAR STRESS
M.D. Hope, T.A. Hope, A.K. Meadows, K.G. Ordovas,
T.H. Urbania,
M.T. Alley, C.B. Higgins, UCSF, San Francisco, CA, USA |
423 |
12:45 |
RISK FACTORS DETERMINING OUTCOME AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION: ANALYSIS OF 300 PATIENTS
R. Bauernschmitt, S. Bleiziffer, H. Ruge,
D. Mazzitelli, A. Hutter, A. Opitz,
G. Brockmann,
I. Hettich, R. Lange, German Heart Center, Munich, Germany |
424 |
13:00 |
TRANSAPICAL TRANSCATHETER AORTIC VALVE IMPLANTATION - INFLUENCE OF A LEARNING CURVE ON CLINICAL OUTCOMES
M. Thielmann, D. Wendt, P. Kahlert, P. Tossios,
H. Eggebrecht, R. Erbel,
H. Jakob, West German Heart Center, Essen, NRW, Germany |
425 |
13:15 |
TRANSCATHETER DEVICE CLOSURE OF PERIVALVULAR REGURGITATION
B.A. Love, A. Mittnacht, G.W. Fischer, J. Kalman,
D.H. Adams
Mount Sinai Medical Center, New York, NY, USA |
426 |
TUESDAY, JULY 27, 2010 |
11:00-12:30 |
|
HALL C |
|
S36 Session
METABOLIC SYNDROME, TYPE II DIABETES AND ATHEROSCLEROSIS
Chairpersons:
Y. Charuzi, Los Angeles, CA, USA
U. Keil, Muenster, Germany
|
|
11:00 |
NUCLEAR AND MITOCHONDRIAL TRANSLOCATION OF PHOSPHORYLATED PKCÄ ASSOCIATES WITH TUNEL-POSITIVE AND UROCORTINNEGATIVE STAINING IN THE HUMAN HEART FROM DIABETIC PATIENTS UNDERGOING ON-PUMP CARDIAC SURGERY
C. Chen-Scarabelli, S. Saravolatz, L.D. Saravolatz II,
G.M. Scarabelli, G. Chen,
J. Di Rezze, L. Saravolatz,
T.M. Scarabelli, VA Medical Center, Ann Arbor, University of Michigan, MI, USA |
427 |
11:15 |
INDEPENDENT CONTRIBUTION OF THE HYPERTRIGLYCERIDEMIC-WAIST PHENOTYPE TO THE CARDIOMETABOLIC RISK IN WOMEN
J. Methot, D. Brisson, D. Gaudet,
Department of Medicine, Université de Montréal, Montréal, Canada
|
428 |
11:30 |
RELATIONSHIP BETWEEN FASTING PLASMA GLUCOSE AND HEMOGLOBIN A1C AND PREDICTING DIABETES: THE STRONG HEART STUDY
J.W. Wang, E.T. Lee,
Center for American Indian Health Research, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA |
429 |
11:45 |
LOW DENSITY LIPOPROTEIN FROM LDL RECEPTOR NULL MICS IS SUCEPTIBLE TO OXIDATIVE MODIFICATION
K. Navab, S. Hama, G. Hough, David Geffen School of Medicine, UCLA,
Los Angeles, CA, USA |
430 |
12:00 |
THE ASSOCIATION OF ADIPONECTIN WITH THE METABOLIC SYNDROME IN WOMEN IS INDEPENDENT OF THE MENOPAUSAL STATUS
Y. Loucif, J. Méthot, D. Brisson, D. Gaudet,
Université de Montreal, ECOGENE-21 Clinical research Center, Chicoutimi Hospital, Chicoutimi, Quebec, Canada
|
431 |
12:15 |
CAN EVIDENCE BASED THERAPY REDUCE DISPARITY OF OUTCOMES BETWEEN DIABETIC MEN AND WOMEN?
A.S. Volgman, A. Khandelwal, L. Fogg,
G.L. Schaer, L. Li, S. Sahota,
T. Bornstein,
E. Frankel, P. Patel, J.E. Calvin
Rush University Medical Center, Chicago, IL, USA |
432 |
|
|